Carraguard (PC-515)
Carraguard (PC-515) is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women
Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission
Safety and Acceptability of Carraguard® in HIV Positive Women and Men
Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand
Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission
Clinical Trials (6)
A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women
Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission
Safety and Acceptability of Carraguard® in HIV Positive Women and Men
Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand
Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission
Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6